Truist raised the firm’s price target on SI-Bone (SIBN) to $18 from $16 and keeps a Buy rating on the shares after its Q3 results. The quarter’s positives far outweighed the negatives, with a Hurricane-impacted revenue miss that was overshadowed by the management’s reiterated 19%-2-% growth trajectory outlook and positive new product launches, the analyst tells investors in a research note.
Don't Miss our Black Friday Offers:
- Unlock your investing potential with TipRanks Premium - Now At 40% OFF!
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter